Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara.

about

Matrix and backstage: cellular substrates for viral vaccines Large-scale adenovirus and poxvirus-vectored vaccine manufacturing to enable clinical trials.Continuous cell lines from the Muscovy duck as potential replacement for primary cells in the production of avian vaccines.

P2860

Q27025941-EF06BDEF-94AF-4E86-A422-74D254735E8F Q38443390-176B7716-9AE8-4471-AFA0-EAFEBAC335E1 Q38799241-08455E13-48E6-4851-8B36-F86CEFA08190

P2860

Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara.

Item

http://www.wikidata.org/entity/Q38970262

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara.

@en

type

Item

label

Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara.

@en

prefLabel

Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara.

@en

P1476

Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara

@en

P2093

Udo Reichl

http://www.w3.org/2001/XMLSchema#string

Verena Lohr

http://www.w3.org/2001/XMLSchema#string

Volker Sandig

http://www.w3.org/2001/XMLSchema#string

Yvonne Genzel

http://www.w3.org/2001/XMLSchema#string

P2860

Initial sequencing and analysis of the human genome

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

The duck genome and transcriptome provide insight into an avian influenza virus reservoir species

Long-term reinfection of the human genome by endogenous retroviruses

Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer

Poxvirus cell entry: how many proteins does it take?

Protective Antiviral Immunity Conferred by a Nonintegrative Lentiviral Vector-Based Vaccine

Vaccines: the Fourth Century

Discovery of antivirals against smallpox

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

P304

100-121

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/MICROORGANISMS1010100

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ingo Jordan

P577

2013-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27694766

http://www.w3.org/2001/XMLSchema#string

P932

5029493

http://www.w3.org/2001/XMLSchema#string

Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara.

about

P2860

P2860

Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932